Epstein Secrets

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

Krasny, 4.73M), USA Today <https://vvww.usatoday.corn/story/news/politics/2020/07/30/herman-cain-dies-after-battle-covid- 19/5544484002/> (7/30, Wu, Santucci, 10.31 M), the Washington Times <https://vvww.washingtontimes.com/news/2020/jul/30/herman-cain-2012-gop-presidential-candidate-dies-a/> (7/30, Sher

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

to uphold the independence of a Justice Department that had suffered deep politicization under the Trump administration." USA Today (2/22, Behrmann, Santucci, 12.7M) reports, "Garland was often pressed by Republican senators over the political independence of the Justice Department, and was pressed, to w

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

rman Cain, Ex-Presidential Candidate Who Refused To Wear Mask, Dies After COVID-19 Diagnosis." Bloomberg (7/30, Krasny, 4.73M), USA Today (7/30, Wu, Santucci, 10.31M), the Washington Times (7/30, Sherfinski, 492K), Axios (7/30, Perano, 521K), and the Wall Street Journal (7/30, McCormick, Subscription Pub

ine Use. The Washington Post (4/22, Al, McGinley, Sun, 10.52M) reports, "Federal health authorities are leaning toward recommending that use of the Johnson & Johnson coronavirus vaccine resume, possibly as soon as this weekend - a move that would include a new warning about a rare complication involving blood cl

rted during the Trump administration appears to be coming to an end" with the announcement. Thunberg Testifies Before House Panel. USA Today (4/22, Santucci, 12.7M) reports, "Teen climate activist Greta Thunberg called tax breaks for the fossil fuel industry a 'disgrace' in testimony to Congress at an E

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

rman Cain, Ex-Presidential Candidate Who Refused To Wear Mask, Dies After COVID-19 Diagnosis." Bloomberg (7/30, Krasny, 4.73M), USA Today (7/30, Wu, Santucci, 10.31M), the Washington Times (7/30, Sherfinski, 492K), Axios (7/30, Perano, 521K), and the Wall Street Journal (7/30, McCormick, Subscription Pub